Vivos Therapeutics (VVOS) Earnings Report - Discounting Cash Flows
Vivos Therapeutics, Inc.
VVOS (NASDAQ)

* (except for per share items) of USD
Period Ending: 2025
08-12
2025
05-12
2025
03-26
2024
11-12
2024
08-14
2024
05-14
2024
03-28
2023
11-14
2023
08-16
2023
03-30
2022
12-20
2022
09-29
2022
08-23
2022
05-16
2021
12-30
2021
11-15
2021
08-12
2021
05-17
2020
12-14
2020
09-30
2020
06-30
2020
03-31
2019
12-31
2019
09-30
Actual EPS - - - - -0.60 -1.63 -3.05 -1.75 -3.75 -5.00 -8.25 -6.43 -8.27 -6.50 -22.00 -6.50 -4.75 -4.75 -11.32 -3.63 -2.83 -5.17 -5.28 -6.24
Estimated EPS - - - -0.61 -1.05 -1.17 -1.90 -3.12 -3.75 -5.50 -0.28 - - -7.25 - -4.00 -4.00 -4.25 - - - - - -
Actual Revenue - - - - 4.05 3.42 3.25 3.30 3.40 3.86 3.95 4.25 4.18 3.46 4.39 4.55 4.50 3.45 3.31 3.29 3.27 3.20 3.06 3.32
Estimated Revenue - - - 4.06 3.60 3.71 3.41 - 4.14 4.01 3.81 - 3.81 - - 4.50 4.50 - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us